Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody

Clinical Cancer Research

Volumn 6, Issue 5, 2000, Pages 1711-1719

  Mayer, Astrid ^a   Tsiompanou, Eleni ^a   O'Malley, Denise ^a   Boxer, Geoff M ^a   Bhatia, Jeetendra ^a   Flynn, Aiden A ^a   Chester, Kerry A ^a   Davidson, Brian R ^b   Lewis, Adam A M ^b   Winslet, Mark C ^b   Dhillon, Amar P ^b   Hilson, Andrew J W ^b   Begent, Richard H J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; DIAGNOSTIC ACCURACY; FEMALE; GENETIC ENGINEERING; HUMAN; ISOTOPE LABELING; LIVER METASTASIS; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL; RADIOSURGERY; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; CARCINOEMBRYONIC ANTIGEN; COLON; COLORECTAL NEOPLASMS; DNA, RECOMBINANT; FEMALE; GENETIC ENGINEERING; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RADIOIMMUNODETECTION; TISSUE DISTRIBUTION;

EID: 17044454065     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Verhaar, M. J., Chester, K. A., Keep, P. A., Robson, L., Pedley, R. B., Boden, J. A., Hawkins, R. E., and Begent, R. H. J. A single chain Fv derived from a filamentous phage library has distinct tumor targeting advantages over one derived from a hybridoma. Int. J. Cancer, 61: 497-501, 1995.
2. Begent, R. H. J., Verhaar, M. J., Chester, K. A., Casey, J. L., Green, A. J., Napier, M. P., Hope-Stone, L. D., Cushen, N., Keep, P. A., Johnson, C. J., Hawkins, R. E., Hilson, A. J. W., and Robson, L. Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library. Nat. Med., 2: 979-984, 1996.
3. Enker, W. E., Laffer, U. T., and Block, G. E. Enhanced survival of patients with colon and rectal cancer is based upon wide anatomic resection. Ann. Surg., 190: 350-360, 1979.
4. Aitken, D. R., Hinkle, G. H., and Thurston, M. O. A gamma detecting probe for radioimmunodetection of CEA-producing tumors: successful experimental use and clinical case report. Dis. Colon Rectum, 27: 279-282, 1984.
5. Cohen, A. M., Martin, E. W., Lavery, I., Daly, J., Sardi, A., Aitken, D., Bland, K., Mojzisik, C., and Hinkle, G. Radioimmunoguided surgery using iodine 125 B72.3 in patients with colorectal cancer. Arch. Surg., 126: 349-352, 1991.
6. Arnold, M. W., Hitchcock, C. L., Young, D. C., Burak, W. E., Bertsch, D. J., and Martin, E. W. Intra-abdominal patterns of disease dissemination in colorectal cancer identified using radioimmunoguided surgery. Dis. Colon Rectum, 39: 509-513, 1996.
7. Dawson, P. M., Blair, S. D., Begent, R. H. J., Kelly, A. M. B., Boxer, G. M., and Theodorou, N. A. The value of radioimmunoguided surgery in first and second look laparotomy for colorectal cancer. Dis. Colon Rectum, 34: 217-222, 1991.
8. Chester, K. A., Begent, R. H. J., Robson, L., Keep, P., Pedley, R. B, Boden, J. A., Boxer, G., Green, A., Winter, G., Cochet, O., and Hawkins, R. E. Phage libraries for generation of clinically useful antibodies. Lancet, 343: 455-456, 1994.
9. Casey, J. L., Keep, P. A., Chester, K. A., Robson, L., Hawkins, R. E., and Begent, R. H. J. Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography. J. Immunol. Methods, 179: 105-116, 1995.
10. Begent, R. H. J., Chester, K. A., Connors, T., Crowther, D., Fox, B., Griffiths, E., Hince, T. A., Ledermann, J. A., McVie, J. G., Minor, P., Secher, D. S., Schwartsrnann, G., Thorpe, R., Wilbin, C., and Zwierzina, H. Cancer Research Campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in Phase I trials. Eur. J. Cancer, 29A: 1907-1910, 1993.
11. Mayer, A., Chester, K. A., Bhatia, J., Pedley, R. B., Read, D. A., Boxer, G. M., and Begent, R. H. J. Exemplifying guidelines for preparation of recombinant DNA products in Phase I trials in cancer: preparation of a genetically engineered anti-CEA single chain Fv antibody. Eur. J. Cancer, 34: 968-976, 1998.
12. Flynn, A. A., Green, A. J., Boxer, G. M., Casey, J. L., Pedley, R. B., and Begent, R. H. J. A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft model. Int. J. Radiat. Oncol. Biol. Phys., 43: 183-189, 1999.
13. Yokota, T., Milenic, D. E., Whitlow, M., Wood, J. F., Hubert, S. L., and Schlom, J. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. Cancer Res., 53: 3776-3783, 1993.
14. Arnold, M. W., Schneebaum, S., Berens, A., Petty, L., Mojzisik, K., Hinkle, G., and Martin, E. W. Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody. Ann. Surg., 216: 627-632, 1992.
15. Burak, W. E., Schneebaum, S., Kim, J. A., Arnold, M. W., Hinkle, G., Berens, A., Mojzisik, C., and Martin, E. W. Pilot study evaluating the intraoperative localization of radiolabeled monoclonal antibody CC83 in patients with metastatic colorectal carcinoma. Surgery, 118: 103-108, 1995.
16. Michael, N. P., Chester, K. A., Melton, R. G., Robson, L., Nicholas, W., Boden, J. A., Pedley, R. B., Begent, R. H. J., Sherwood, R. F., and Minton, N. P. In vitro and in vivo characterisation of a recombinant carboxypeptidase G(2):anti-CEA scFv fusion protein. Immunotechnology, 2: 47-57, 1996.